An Open-label, Randomized, Crossover Study to Evaluate the Bioavailability of Two Candidate Tablet Formulations of ABT-450 With Reference to the Hard Gelating Capsule Formulation.
Phase of Trial: Phase I
Latest Information Update: 20 Dec 2010
At a glance
- Drugs Paritaprevir (Primary) ; Ritonavir
- Indications Hepatitis C
- Focus Pharmacokinetics
- 07 Jul 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 07 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jun 2010 Actual number of patients added to 41 as reported by ClinicalTrials.gov.